Swiss National Bank Has $2.39 Million Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

The Swiss National Bank has recently increased its stake in LeMaitre Vascular, Inc. NASDAQLMAT by 1.2% during the third quarter of the year. This was disclosed in the company's most recent 13F filing with the Securities and Exchange Commission. According to this filing, the bank now owns 43,900 shares of LeMaitre Vascular's stock after purchasing an additional 500 shares during the quarter.

LeMaitre Vascular is a medical instruments supplier that specializes in providing products for minimally invasive surgical procedures. The company's product portfolio includes devices for cardiovascular, neurovascular, and orthopedic surgeries. LeMaitre Vascular's stock is listed on the NASDAQ Global Select Market under the symbol "MAT".

The Swiss National Bank is a central bank of Switzerland that manages the country's monetary policy and supervises financial institutions. The bank has been in operation since 1845 and is one of the oldest central banks in the world. The bank's investment portfolio includes a wide range of assets, including stocks, bonds, and real estate.

Investing in LeMaitre Vascular, Inc. NASDAQLMAT could be seen as an opportunity for the Swiss National Bank to diversify its investment portfolio and gain exposure to the medical instruments industry. The bank's decision to increase its stake in the company suggests that it sees potential growth opportunities in this sector.

It is important to note that the information provided is based on publicly available data and should not be considered as financial advice. It is always recommended to consult with a financial advisor before making any investment decisions.